Aleksandr N. Uskov
Research Subjects
Research Interests
Aleksandr N. Uskov has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Yuriy V. Lobzin
Pediatric Research and Clinical Center for Infectious Diseases
6 shared publications - Natal'YA Viktorovna Skripchenko
Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russian Federation
3 shared publications - Aleksandr Aleksandrovich Baranov
Russian Scientific Center of Surgery named after B. V. Petrovsky; I. M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications Alexey V. Yakovlev
Saint Petersburg State Pediatric Medical University
2 shared publicationsAlexey Yu. Rtishchev
Pirogov Russian National Research Medical University
2 shared publications- Alla A. Vilnits
Federal Research and Clinical Center for Infectious Diseases; Saint Petersburg State Pediatric Medical University
2 shared publications
Latest Publications
- Open Access
- 5 August 2025
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 44 (2) , 219-227
Ecology of dengue virus
Dengue virus and its interactions with Aedes mosquito vectors and human hosts have garnered significant scientific interest over the past decade. Despite extensive research, many aspects of these interactions remain poorly understood, highlighting the need for further investigation to develop effective therapeutic and preventive strategies to reduce the spread of dengue virus and the prevalence of the disease. The key challenges underpinning the relevance of dengue virus studies include the insufficient current preventive measures, the limited efficacy of approved vaccines, the absence of antiviral therapies with proven clinical efficacy, the risk of complications, and other factors. The review provides a characterization of dengue virus virions, highlighting the four virus serotypes, mutation rates and genome evolution. Genotypic and serotypic variations, which are regularly identified through the study of regional viral circulation, have the potential to give rise to new dengue strains, which can cause subsequent epidemics. The review details the stages of the viral life cycle in vertebrate and invertebrate hosts. Viral replication, transcription, and translation within cells of vertebrate and invertebrate hosts are examined, along with both typical and atypical routes of infection transmission. The ecology of A. aegypti and A. albopictus vectors, vector competence and the factors that reduce vector competence under natural conditions are discussed. Strategies for targeted intervention in the interactions between the pathogen, vector, and vertebrate host are examined. The most probable driver for the global expansion of the virus is the active migration of infected individuals. Research focused on identifying critical points in the protein interactions of the pathogen, vertebrate and invertebrate hosts, and exploring mechanisms to inhibit these interactions, appears promising for reducing the risk of dengue infection. The detection of imported cases of dengue fever in Russia underscores the need to implement measures for increasing public awareness regarding transmissible diseases and to minimize contact with potentially infected individuals when visiting tropical and subtropical regions.
- 5 August 2025
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 44 (2) , 219-227
Open AccessEcology of dengue virus
Dengue virus and its interactions with Aedes mosquito vectors and human hosts have garnered significant scientific interest over the past decade. Despite extensive research, many aspects of these interactions remain poorly understood, highlighting the need for further investigation to develop effective therapeutic and preventive strategies to reduce the spread of dengue virus and the prevalence of the disease. The key challenges underpinning the relevance of dengue virus studies include the insufficient current preventive measures, the limited efficacy of approved vaccines, the absence of antiviral therapies with proven clinical efficacy, the risk of complications, and other factors. The review provides a characterization of dengue virus virions, highlighting the four virus serotypes, mutation rates and genome evolution. Genotypic and serotypic variations, which are regularly identified through the study of regional viral circulation, have the potential to give rise to new dengue strains, which can cause subsequent epidemics. The review details the stages of the viral life cycle in vertebrate and invertebrate hosts. Viral replication, transcription, and translation within cells of vertebrate and invertebrate hosts are examined, along with both typical and atypical routes of infection transmission. The ecology of A. aegypti and A. albopictus vectors, vector competence and the factors that reduce vector competence under natural conditions are discussed. Strategies for targeted intervention in the interactions between the pathogen, vector, and vertebrate host are examined. The most probable driver for the global expansion of the virus is the active migration of infected individuals. Research focused on identifying critical points in the protein interactions of the pathogen, vertebrate and invertebrate hosts, and exploring mechanisms to inhibit these interactions, appears promising for reducing the risk of dengue infection. The detection of imported cases of dengue fever in Russia underscores the need to implement measures for increasing public awareness regarding transmissible diseases and to minimize contact with potentially infected individuals when visiting tropical and subtropical regions.
- Open Access
- 9 December 2022
- Published by Federal Research and Clinical Center for Resuscitation and Rehabilitation in Physical and rehabilitation medicine, medical rehabilitation
- Vol. 4 (4) , 223-233
Assessment of rehabilitation in children with infectious diseases of the lower respiratory tract using the categories of the International Classification of Functioning, Disability and Health
BACKGROUND: Solving the issues of rehabilitation of children after lower respiratory tract infections requires putting up rehabilitation diagnoses in the categories of the International Classification of Functioning, Disabilities and Health (ICF). AIMS: The study aimed to define the key problems in the ICF categories and make quantitative and qualitative assessments of the changes in the ICF domains in convalescent children with infectious diseases of the lower respiratory tract at the outpatient stage and in one month after the disease. MATERIALS AND METHODS: The assessment of rehabilitation was performed using the ICF categories for 201 convalescent children with lower respiratory tract infections. RESULTS: Most of the patients had significant impairments in the following functions: b134 Sleep functions; b152 Emotional functions; b280 Feeling of pain; b440 Respiratory functions; b450 Additional respiratory functions; b455 Exercise tolerance function; b460 Sensations associated with cardiovascular and respiratory functions; b730 Muscle strength functions; b740 Muscular endurance functions; b780 Sensations associated with muscles and motor functions, both at the time of discharge from the hospital and a month after the discharge. Environmental factors (e115 Products and technologies for personal use in daily life; e225 Climate; e260 Air quality; e310 Close relatives; e355 Medical workers; e410 Relationships with immediate family members; e450 Relationships with medical workers; e580 Medical services; e585 Services in education and training) were shown to have an influence on rehabilitation process. CONCLUSION: The identified range of functioning disorders and the influence of environmental factors indicates the need for medical rehabilitation for convalescent children with lower respiratory tract infections. The rehabilitation should be multidisciplinary and involve psychological and pedagogical techniques, work with the family, and motor rehabilitation techniques to restore workload tolerance.
- 9 December 2022
- Published by Federal Research and Clinical Center for Resuscitation and Rehabilitation in Physical and rehabilitation medicine, medical rehabilitation
- Vol. 4 (4) , 223-233
Open AccessAssessment of rehabilitation in children with infectious diseases of the lower respiratory tract using the categories of the International Classification of Functioning, Disability and Health
BACKGROUND: Solving the issues of rehabilitation of children after lower respiratory tract infections requires putting up rehabilitation diagnoses in the categories of the International Classification of Functioning, Disabilities and Health (ICF). AIMS: The study aimed to define the key problems in the ICF categories and make quantitative and qualitative assessments of the changes in the ICF domains in convalescent children with infectious diseases of the lower respiratory tract at the outpatient stage and in one month after the disease. MATERIALS AND METHODS: The assessment of rehabilitation was performed using the ICF categories for 201 convalescent children with lower respiratory tract infections. RESULTS: Most of the patients had significant impairments in the following functions: b134 Sleep functions; b152 Emotional functions; b280 Feeling of pain; b440 Respiratory functions; b450 Additional respiratory functions; b455 Exercise tolerance function; b460 Sensations associated with cardiovascular and respiratory functions; b730 Muscle strength functions; b740 Muscular endurance functions; b780 Sensations associated with muscles and motor functions, both at the time of discharge from the hospital and a month after the discharge. Environmental factors (e115 Products and technologies for personal use in daily life; e225 Climate; e260 Air quality; e310 Close relatives; e355 Medical workers; e410 Relationships with immediate family members; e450 Relationships with medical workers; e580 Medical services; e585 Services in education and training) were shown to have an influence on rehabilitation process. CONCLUSION: The identified range of functioning disorders and the influence of environmental factors indicates the need for medical rehabilitation for convalescent children with lower respiratory tract infections. The rehabilitation should be multidisciplinary and involve psychological and pedagogical techniques, work with the family, and motor rehabilitation techniques to restore workload tolerance.
- Open Access
- 8 July 2021
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 20 (2) , 49-56
Improving the therapy of generalized forms of Meningococcal infection in children using extracorporeal hemocorrection
Invasive meningococcal infection is a significant cause of death, reaching 80% in septic shock. The Pediatric Research and Clinical Center for Infectious Diseases (PRCCID) has developed an algorithm for the treatment of children with invasive meningococcal infection with refractory septic shock and multiple organ failure syndrome, which includes basic drug therapy with polymyxin hemoperfusion in combination with extended methods of extracorporeal hemocorrection.Purpose: to evaluate the effectiveness of extracorporeal hemocorrection operations in children with invasive meningococcal infection with refractory septic shock and multiple organ failure syndrome.Materials and research methods: to the intensive care unit of the PRCCID for the analyzed period 2006—2020 34 children were hospitalized with invasive meningococcal infection with refractory septic shock and multiple organ failure syndrome. Two groups were formed: Group 1 — children admitted to the PRCCID in the period 2014—2020 (n = 23), who underwent polymyxin hemoperfusion simultaneously with extended methods of extracorporeal hemocorrection, group 2 — children hospitalized in 2006—201 3 (n = 1 1), methods of extracorporeal hemocorrection were not performed. The Mann-Whitney U-test and ANOVA were used to evaluate the results.Results and discussion: the use of extracorporeal hemocorrection operations in the complex therapy of invasive forms of meningococcal infection with refractory septic shock and multiple organ failure syndrome in children provides stabilization of central hemodynamics, reduces clinical and laboratory inflammatory reactions, helps to reduce the dose of vasopressor drugs and parameters of respiratory support, and also increases patient survival rate by 82.6%.
- 8 July 2021
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 20 (2) , 49-56
Open AccessImproving the therapy of generalized forms of Meningococcal infection in children using extracorporeal hemocorrection
Invasive meningococcal infection is a significant cause of death, reaching 80% in septic shock. The Pediatric Research and Clinical Center for Infectious Diseases (PRCCID) has developed an algorithm for the treatment of children with invasive meningococcal infection with refractory septic shock and multiple organ failure syndrome, which includes basic drug therapy with polymyxin hemoperfusion in combination with extended methods of extracorporeal hemocorrection.Purpose: to evaluate the effectiveness of extracorporeal hemocorrection operations in children with invasive meningococcal infection with refractory septic shock and multiple organ failure syndrome.Materials and research methods: to the intensive care unit of the PRCCID for the analyzed period 2006—2020 34 children were hospitalized with invasive meningococcal infection with refractory septic shock and multiple organ failure syndrome. Two groups were formed: Group 1 — children admitted to the PRCCID in the period 2014—2020 (n = 23), who underwent polymyxin hemoperfusion simultaneously with extended methods of extracorporeal hemocorrection, group 2 — children hospitalized in 2006—201 3 (n = 1 1), methods of extracorporeal hemocorrection were not performed. The Mann-Whitney U-test and ANOVA were used to evaluate the results.Results and discussion: the use of extracorporeal hemocorrection operations in the complex therapy of invasive forms of meningococcal infection with refractory septic shock and multiple organ failure syndrome in children provides stabilization of central hemodynamics, reduces clinical and laboratory inflammatory reactions, helps to reduce the dose of vasopressor drugs and parameters of respiratory support, and also increases patient survival rate by 82.6%.
- Open Access
- 30 March 2021
- Published by SPRIDA in Journal Infectology
- Vol. 13 (1) , 13-20-20
Pediatric multisystem inflammatory syndrome associated with a new coronavirus infection: unresolved issues
С марта 2020 г. появились первые сообщения о возрастающем практически повсеместно количестве детей, перенесших новую короновирусную инфекцию, вызванную SARS-Co2v, с симптомокомплексом, напоминающим проявления болезни Кавасаки. Особенностью клинических проявлений при данном синдроме, который получил название «педиатрический мультисистемный воспалительный синдром, ассоциированный с COVID-19», является высокая частота возникновения жизнеугрожающих состояний, обусловленных резким развитием артериальной гипотензии на фоне кардиогенного или вазогенношого шока. В Санкт-Петербурге с конца декабря 2020 г. наблюдается резкий всплеск поступлений в ОРИТ различных стационаров детей с клиникой педиатрического мультисистемного воспалительного синдрома, имеющих лабораторное подтверждение перенесенного COVID-19. Целью настоящей статьи является привлечение внимания врачей различного профиля для объединения усилий по изучению данной патологии, определения критериев верификации диагноза, оптимальных схем терапии и диспансерного наблюдения за переболевшими.
- 30 March 2021
- Published by SPRIDA in Journal Infectology
- Vol. 13 (1) , 13-20-20
Open AccessPediatric multisystem inflammatory syndrome associated with a new coronavirus infection: unresolved issues
С марта 2020 г. появились первые сообщения о возрастающем практически повсеместно количестве детей, перенесших новую короновирусную инфекцию, вызванную SARS-Co2v, с симптомокомплексом, напоминающим проявления болезни Кавасаки. Особенностью клинических проявлений при данном синдроме, который получил название «педиатрический мультисистемный воспалительный синдром, ассоциированный с COVID-19», является высокая частота возникновения жизнеугрожающих состояний, обусловленных резким развитием артериальной гипотензии на фоне кардиогенного или вазогенношого шока. В Санкт-Петербурге с конца декабря 2020 г. наблюдается резкий всплеск поступлений в ОРИТ различных стационаров детей с клиникой педиатрического мультисистемного воспалительного синдрома, имеющих лабораторное подтверждение перенесенного COVID-19. Целью настоящей статьи является привлечение внимания врачей различного профиля для объединения усилий по изучению данной патологии, определения критериев верификации диагноза, оптимальных схем терапии и диспансерного наблюдения за переболевшими.
- Open Access
- 20 August 2020
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 17 (3) , 187-212
Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children. Version 2
The Ministry of Health of the Russian Federation jointly with professional association and experts in the field of pediatrics, infectious diseases and resuscitation has revised guidelines “Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children” in order to provide the child population with effective medical care during the pandemic of the new coronaviral infection. The practical experience of specialists from various countries was considered during the development of this document. Special attention should be given to the evidence base of the presented data, as well as to the efficiency and safety issues of medications used in treatment of coronaviral infection and its complications. The authors highlight the problems of prevention, diagnostics and management of pathological conditions caused by COVID-19 in the article according to the presented guidelines. Patient’s management is presented depending on the age and severity of the disease itself. The therapy is considered with regard to etiological, pathogenetic and symptom focus.
- 20 August 2020
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 17 (3) , 187-212
Open AccessClinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children. Version 2
The Ministry of Health of the Russian Federation jointly with professional association and experts in the field of pediatrics, infectious diseases and resuscitation has revised guidelines “Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children” in order to provide the child population with effective medical care during the pandemic of the new coronaviral infection. The practical experience of specialists from various countries was considered during the development of this document. Special attention should be given to the evidence base of the presented data, as well as to the efficiency and safety issues of medications used in treatment of coronaviral infection and its complications. The authors highlight the problems of prevention, diagnostics and management of pathological conditions caused by COVID-19 in the article according to the presented guidelines. Patient’s management is presented depending on the age and severity of the disease itself. The therapy is considered with regard to etiological, pathogenetic and symptom focus.
- Open Access
- 14 August 2020
- Published by Kuban State Medical University in Kuban Scientific Medical Bulletin
- Vol. 27 (4) , 119-133
Current trends in paediatric infections in the Russian Federation
The onset of 2020 clearly demonstrated that infection agents pose a major threat to mankind. Current infectiology is shaped by resurrection of “old” seemingly forgotten infections, emergence of “new” infection agents, unusual combinations of known agents, evolving resistance of microorganisms to antibacterial drugs, transformation of human microbiome leading to distortions in herd immunity and, ultimately, emergence of healthcare-related infectious diseases, not letting alone threats of bioterror. Infection agents evolve together with mankind. Novel facets emerge in infectiology, alongside with trends in diagnosis, treatment and prevention of infectious diseases that become more diverse as the list of pathogens grows. Human and infection agent links extend beyond antagonistic relations towards symbiosis. Microorganisms adapt quickly in the new technogenic environment giving rise to novel pathogens and making it unlikely for the mankind to get free from infections any time soon.The total economic damage from infectious diseases increases by year, despite continuous improvement in therapy. Infectious mortality in children aged 0 to 14 years is the top fourth among other causes of death. The work assesses comparative dynamics of “common” childhood infections in the Russian Federation during 2018–2020. We analyse official statistics on paediatric infectious morbidity, comparative dynamics of main infectious diseases (acute respiratory diseases, intestinal infections of bacterial and viral nature, neuroinfections, anthropozoonotic infections, viral hepatitises), assess trends in morbidity of vaccine-preventable infections in children and adults in the Russian Federation, with greater detail towards selected regions, from January 2018 to April 2020.
- 14 August 2020
- Published by Kuban State Medical University in Kuban Scientific Medical Bulletin
- Vol. 27 (4) , 119-133
Open AccessCurrent trends in paediatric infections in the Russian Federation
The onset of 2020 clearly demonstrated that infection agents pose a major threat to mankind. Current infectiology is shaped by resurrection of “old” seemingly forgotten infections, emergence of “new” infection agents, unusual combinations of known agents, evolving resistance of microorganisms to antibacterial drugs, transformation of human microbiome leading to distortions in herd immunity and, ultimately, emergence of healthcare-related infectious diseases, not letting alone threats of bioterror. Infection agents evolve together with mankind. Novel facets emerge in infectiology, alongside with trends in diagnosis, treatment and prevention of infectious diseases that become more diverse as the list of pathogens grows. Human and infection agent links extend beyond antagonistic relations towards symbiosis. Microorganisms adapt quickly in the new technogenic environment giving rise to novel pathogens and making it unlikely for the mankind to get free from infections any time soon.The total economic damage from infectious diseases increases by year, despite continuous improvement in therapy. Infectious mortality in children aged 0 to 14 years is the top fourth among other causes of death. The work assesses comparative dynamics of “common” childhood infections in the Russian Federation during 2018–2020. We analyse official statistics on paediatric infectious morbidity, comparative dynamics of main infectious diseases (acute respiratory diseases, intestinal infections of bacterial and viral nature, neuroinfections, anthropozoonotic infections, viral hepatitises), assess trends in morbidity of vaccine-preventable infections in children and adults in the Russian Federation, with greater detail towards selected regions, from January 2018 to April 2020.
- Open Access
- 10 June 2020
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 17 (2) , 103-118
Management of Children with Disease Caused by New Coronaviral Infection (SARS-CoV-2)
The Ministry of Health of the Russian Federation jointly with professional association and experts in the field of pediatrics, infectious diseases and resuscitation has developed guidelines “Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children” in order to provide the child population with effective medical care during the pandemic of the new coronaviral infection. The practical experience of specialists from various countries was considered during the development of this document. Special attention should be given to the evidence base of the presented data, as well as to the efficiency and safety issues of medications used in treatment of coronaviral infection and its complications. The authors highlight the problems of prevention, diagnostics and management of pathological conditions caused by COVID-19 in the article according to the presented guidelines. Patient’s management is presented depending on the age and severity of the disease itself. The therapy is considered with regard to etiological, pathogenetic and symptom focus.
- 10 June 2020
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 17 (2) , 103-118
Open AccessManagement of Children with Disease Caused by New Coronaviral Infection (SARS-CoV-2)
The Ministry of Health of the Russian Federation jointly with professional association and experts in the field of pediatrics, infectious diseases and resuscitation has developed guidelines “Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children” in order to provide the child population with effective medical care during the pandemic of the new coronaviral infection. The practical experience of specialists from various countries was considered during the development of this document. Special attention should be given to the evidence base of the presented data, as well as to the efficiency and safety issues of medications used in treatment of coronaviral infection and its complications. The authors highlight the problems of prevention, diagnostics and management of pathological conditions caused by COVID-19 in the article according to the presented guidelines. Patient’s management is presented depending on the age and severity of the disease itself. The therapy is considered with regard to etiological, pathogenetic and symptom focus.
- Open Access
- 1 January 2017
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 14 (6) , 494-500
Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Adolescent Girls in Russian Federation
Фармакоэкономические аспекты вакцинации против папилломавирусной инфекции девочек-подростков в Российской Федерации
- 1 January 2017
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 14 (6) , 494-500
Open AccessCost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Adolescent Girls in Russian Federation
Фармакоэкономические аспекты вакцинации против папилломавирусной инфекции девочек-подростков в Российской Федерации